Literature DB >> 18182389

Homophilic interactions of the amyloid precursor protein (APP) ectodomain are regulated by the loop region and affect beta-secretase cleavage of APP.

Daniela Kaden1, Lisa-Marie Munter, Mangesh Joshi, Carina Treiber, Christoph Weise, Tobias Bethge, Philipp Voigt, Michael Schaefer, Michael Beyermann, Bernd Reif, Gerd Multhaup.   

Abstract

We found previously by fluorescence resonance energy transfer experiments that amyloid precursor protein (APP) homodimerizes in living cells. APP homodimerization is likely to be mediated by two sites of the ectodomain and a third site within the transmembrane sequence of APP. We have now investigated the role of the N-terminal growth factor-like domain in APP dimerization by NMR, biochemical, and cell biological approaches. Under nonreducing conditions, the N-terminal domain of APP formed SDS-labile and SDS-stable complexes. The presence of SDS was sufficient to convert native APP dimers entirely into monomers. Addition of an excess of a synthetic peptide (APP residues 91-116) containing the disulfide bridge-stabilized loop inhibited cross-linking of pre-existing SDS-labile APP ectodomain dimers. Surface plasmon resonance analysis revealed that this peptide specifically bound to the N-terminal domain of APP and that binding was entirely dependent on the oxidation of the thiol groups. By solution-state NMR we detected small chemical shift changes indicating that the loop peptide interacted with a large protein surface rather than binding to a defined pocket. Finally, we studied the effect of the loop peptide added to the medium of living cells. Whereas the levels of alpha-secretory APP increased, soluble beta-cleaved APP levels decreased. Because Abeta40 and Abeta42 decreased to similar levels as soluble beta-cleaved APP, we conclude either that beta-secretase binding to APP was impaired or that the peptide allosterically affected APP processing. We suggest that APP acquires a loop-mediated homodimeric state that is further stabilized by interactions of hydrophobic residues of neighboring domains.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18182389     DOI: 10.1074/jbc.M708046200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif.

Authors:  Lisa-Marie Munter; Anne Botev; Luise Richter; Peter W Hildebrand; Veit Althoff; Christoph Weise; Daniela Kaden; Gerd Multhaup
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein.

Authors:  Sven O Dahms; Sandra Hoefgen; Dirk Roeser; Bernhard Schlott; Karl-Heinz Gührs; Manuel E Than
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

3.  Combined treatment with the phenolics (-)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice.

Authors:  Takashi Mori; Naoki Koyama; Jun Tan; Tatsuya Segawa; Masahiro Maeda; Terrence Town
Journal:  J Biol Chem       Date:  2018-12-18       Impact factor: 5.157

4.  Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization.

Authors:  Luise Richter; Lisa-Marie Munter; Julia Ness; Peter W Hildebrand; Muralidhar Dasari; Stephanie Unterreitmeier; Bruno Bulic; Michael Beyermann; Ronald Gust; Bernd Reif; Sascha Weggen; Dieter Langosch; Gerd Multhaup
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

5.  Lowering of amyloid beta peptide production with a small molecule inhibitor of amyloid-β precursor protein dimerization.

Authors:  Pauline Pl So; Ella Zeldich; Kathleen I Seyb; Mickey M Huang; John B Concannon; Gwendalyn D King; Ci-Di Chen; Gregory D Cuny; Marcie A Glicksman; Carmela R Abraham
Journal:  Am J Neurodegener Dis       Date:  2012

6.  Amyloid precursor protein dimerization and synaptogenic function depend on copper binding to the growth factor-like domain.

Authors:  Frederik Baumkötter; Nadine Schmidt; Carolyn Vargas; Sandra Schilling; Rebecca Weber; Katja Wagner; Sebastian Fiedler; Wilfried Klug; Jens Radzimanowski; Sebastian Nickolaus; Sandro Keller; Simone Eggert; Klemens Wild; Stefan Kins
Journal:  J Neurosci       Date:  2014-08-13       Impact factor: 6.167

7.  Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's disease.

Authors:  Vanessa Schmidt; Katharina Baum; Angelyn Lao; Katja Rateitschak; Yvonne Schmitz; Anke Teichmann; Burkhard Wiesner; Claus Munck Petersen; Anders Nykjaer; Jana Wolf; Olaf Wolkenhauer; Thomas E Willnow
Journal:  EMBO J       Date:  2011-10-11       Impact factor: 11.598

8.  Transmembrane Substrate Determinants for γ-Secretase Processing of APP CTFβ.

Authors:  Marty A Fernandez; Kelly M Biette; Georgia Dolios; Divya Seth; Rong Wang; Michael S Wolfe
Journal:  Biochemistry       Date:  2016-09-30       Impact factor: 3.162

9.  Combination therapy with octyl gallate and ferulic acid improves cognition and neurodegeneration in a transgenic mouse model of Alzheimer's disease.

Authors:  Takashi Mori; Naoki Koyama; Jun Tan; Tatsuya Segawa; Masahiro Maeda; Terrence Town
Journal:  J Biol Chem       Date:  2017-05-16       Impact factor: 5.157

Review 10.  Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease.

Authors:  Elena Anahi Bignante; Florencia Heredia; Gerardo Morfini; Alfredo Lorenzo
Journal:  Neurobiol Aging       Date:  2013-05-25       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.